Abbott K C, Oliver J D, Hypolite I, Lepler L L, Kirk A D, Ko C W, Hawkes C A, Jones C A, Agodoa L Y
Nephrology Service, Walter Reed Army Medical Center, Washington, DC 20307-5001, USA.
Am J Nephrol. 2001 Mar-Apr;21(2):120-7. doi: 10.1159/000046234.
It is common belief in the transplant community that rates of septicemia in transplant recipients have declined, but this has not been studied in a national population.
Therefore, 33,479 renal transplant recipients in the United States Renal Data System from July 1, 1994 to June 30, 1997 were analyzed in a retrospective registry study of the incidence, associated factors, and mortality of hospitalizations with a primary discharge diagnosis of septicemia (ICD9 Code 038.x).
Renal transplant recipients had an adjusted incidence ratio of hospitalizations for septicemia of 41.52 (95% CI 35.45-48.96) compared to the general population. Hospitalizations for septicemia were most commonly associated with urinary tract infection as a secondary diagnosis (30.6%). In multivariate analysis, diabetes and urologic disease, female gender, delayed graft function, rejection, and pre-transplant dialysis, but not induction antibody therapy, were associated with hospitalizations for septicemia. Recipients hospitalized for septicemia had a mean patient survival of 9.03 years (95% CI 7.42-10.63) compared to 15.73 years (95% CI 14.77-16.69) for all other recipients.
Even in the modern era, renal transplant recipients remain at high risk for hospitalizations for septicemia, which are associated with substantially decreased patient survival. Newly identified risks in this population were female recipients and pre-transplant dialysis.
移植界普遍认为移植受者败血症的发生率有所下降,但尚未在全国人群中进行研究。
因此,在一项回顾性登记研究中,对1994年7月1日至1997年6月30日美国肾脏数据系统中的33479名肾移植受者进行了分析,研究原发性出院诊断为败血症(国际疾病分类第九版代码038.x)的住院发生率、相关因素及死亡率。
与普通人群相比,肾移植受者败血症住院的校正发病率比值为41.52(95%可信区间35.45 - 48.96)。败血症住院最常见的次要诊断为尿路感染(30.6%)。多变量分析显示,糖尿病和泌尿系统疾病、女性性别、移植肾功能延迟、排斥反应以及移植前透析,但不包括诱导抗体治疗,与败血症住院相关。因败血症住院的受者平均生存时间为9.03年(95%可信区间7.42 - 10.63),而所有其他受者为15.73年(95%可信区间14.77 - 16.69)。
即使在现代,肾移植受者发生败血症住院的风险仍然很高,这与患者生存率大幅下降相关。该人群中新发现的风险因素为女性受者和移植前透析。